Literature DB >> 11176683

Low-dose interferon alfa-2b for the treatment of Churg-Strauss syndrome with prominent skin involvement.

C C Termeer1, J C Simon, E Schöpf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11176683

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  7 in total

Review 1.  Targeted biologic approaches to the treatment of systemic vasculitis.

Authors:  Andreea Coca; Jennifer H Anolik
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

2.  A case of churg-strauss syndrome.

Authors:  Ji Hoon Choi; In Su Ahn; Hee Bong Lee; Chun Wook Park; Cheol Heon Lee; Hye Kunng Ahn
Journal:  Ann Dermatol       Date:  2009-05-31       Impact factor: 1.444

Review 3.  Cutting edge issues in the Churg-Strauss syndrome.

Authors:  Wojciech Szczeklik; Bogdan Jakieła; Dariusz Adamek; Jacek Musiał
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 4.  Indications for biotherapy in systemic vasculitides.

Authors:  Loïc Guillevin; Christian Pagnoux; Philippe Guilpain; Boris Bienvenu; Valérie Martinez; Luc Mouthon
Journal:  Clin Rev Allergy Immunol       Date:  2007-02       Impact factor: 10.817

5.  The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?

Authors:  Deanna L McDanel; Barbara A Muller
Journal:  Ther Clin Risk Manag       Date:  2005-06       Impact factor: 2.423

6.  Interferon-α induced remission in three patients with eosinophilic granulomatosis and polyangiitis. A case study.

Authors:  B Seeliger; M Foerster; T Neumann; A Moeser; J Happe; N Kehler; C Kroegel
Journal:  Respir Med Case Rep       Date:  2013-09-26

7.  Interferon-alpha inhibits airway eosinophilia and hyperresponsiveness in an animal asthma model [corrected].

Authors:  Yasuko Kikkawa; Kumiya Sugiyama; Kazuki Obara; Hirokuni Hirata; Yasutsugu Fukushima; Masao Toda; Takeshi Fukuda
Journal:  Asia Pac Allergy       Date:  2012-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.